- Main
Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality
- Hong, Yun Soo;
- Battle, Stephanie L;
- Shi, Wen;
- Puiu, Daniela;
- Pillalamarri, Vamsee;
- Xie, Jiaqi;
- Pankratz, Nathan;
- Lake, Nicole J;
- Lek, Monkol;
- Rotter, Jerome I;
- Rich, Stephen S;
- Kooperberg, Charles;
- Reiner, Alex P;
- Auer, Paul L;
- Heard-Costa, Nancy;
- Liu, Chunyu;
- Lai, Meng;
- Murabito, Joanne M;
- Levy, Daniel;
- Grove, Megan L;
- Alonso, Alvaro;
- Gibbs, Richard;
- Dugan-Perez, Shannon;
- Gondek, Lukasz P;
- Guallar, Eliseo;
- Arking, Dan E
- et al.
Abstract
Mitochondria carry their own circular genome and disruption of the mitochondrial genome is associated with various aging-related diseases. Unlike the nuclear genome, mitochondrial DNA (mtDNA) can be present at 1000 s to 10,000 s copies in somatic cells and variants may exist in a state of heteroplasmy, where only a fraction of the DNA molecules harbors a particular variant. We quantify mtDNA heteroplasmy in 194,871 participants in the UK Biobank and find that heteroplasmy is associated with a 1.5-fold increased risk of all-cause mortality. Additionally, we functionally characterize mtDNA single nucleotide variants (SNVs) using a constraint-based score, mitochondrial local constraint score sum (MSS) and find it associated with all-cause mortality, and with the prevalence and incidence of cancer and cancer-related mortality, particularly leukemia. These results indicate that mitochondria may have a functional role in certain cancers, and mitochondrial heteroplasmic SNVs may serve as a prognostic marker for cancer, especially for leukemia.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-